Tumor cell p38 inhibition to overcome immunotherapy resistance
Jason J. Luke(UPMC Hillman Cancer Center), Riyue Bao(University of Pittsburgh)
Cited by 5
Related Papers
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy
|Journal for ImmunoTherapy of Cancer|2016|510
Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma
|Journal of Clinical Oncology|2021|220